修饰生物疾病的抗风湿药物降低了牛皮关节炎患者血清中的尿酸水平
Dijana Perković1,2, Marin Petrić1, Maja Maleš2
1Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, University Hospital of Split, 21000 Split, Croatia.
Current issues in molecular biology
|March 26, 2025
概括
生物修饰性抗风湿药物 (bDMARDs) 在牛皮关节炎 (PsA) 患者中显著降低了血清尿酸 (SUA) 水平. 干白素-17 (IL-17) 抑制剂显示SUA水平的特别显著下降.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 牛皮关节炎 (PsA) 是一种慢性炎症性疾病.
- 在PsA患者中观察到血清尿酸 (SUA) 水平升高,但治疗的影响尚未完全理解.
研究的目的:
- 研究各种生物修饰疾病的抗风湿药物 (bDMARDs) 对PsA患者的SUA水平的影响.
- 为了比较不同的bDMARD类,特别是IL-17抑制剂和TNFα抑制剂在调节SUA水平方面的疗效.
主要方法:
- 在2007年1月至2021年6月期间,87名PsA患者接受bDMARD治疗的回顾性分析.
- 包括接受IL-17抑制剂 (secukinumab,ixekizumab) 和TNFα抑制剂 (golimumab,infliximab,adalimumab,certolizumab pegol,etanercept) 治疗的患者.
主要成果:
- 在3-6个月后,69%的患者观察到SUA水平的显著下降.
- 平均SUA降低为9.4μmol/L (p=0.039),与TNFα抑制剂 (7.3μmol/L,p=0.386) 相比,在接受IL-17抑制剂 (12.6μmol/L,p=0.013) 治疗的患者中降低更为明显.
- 具体的药物,如戈利穆马布,因弗利西玛布,塞库金乌马布和埃坦塞普特显示显著降低了SUA水平.
结论:
- bDMARDs有效地控制了PsA疾病活动.
- 观察到SUA水平的显著降低,特别是在IL-17抑制剂.
- 需要进一步的研究来确定最有效的bDMARD来降低PsA中的SUA水平.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
119
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
119
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
Antihypertensive Drugs: Action of Diuretics
596
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
596
Drugs for Treatment of Ulcerative Colitis in IBD
114
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
114
Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
320
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
320


